John D. Roache - Publications

Affiliations: 
The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Neuroscience Biology

68/196 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N. Corrigendum to "Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking" [Drug and Alcohol Dependence, 148, (2015), 77-84 doi: 10.1016/j.drugalcdep.2014.12.021] Drug and Alcohol Dependence. 149: 304. DOI: 10.1016/J.Drugalcdep.2015.01.037  0.316
2009 Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo D, Dackis C, Roache JD, Salloum IM, Somoza E, et al. Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence. 104: 133-9. PMID 19560290 DOI: 10.1016/J.Drugalcdep.2009.04.015  0.315
2008 Roache JD, Wang Y, Ait-Daoud N, Johnson BA. Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism. Alcoholism, Clinical and Experimental Research. 32: 1502-12. PMID 18565156 DOI: 10.1111/J.1530-0277.2008.00717.X  0.344
2008 Murff W, Roache JD. SAFETY OF DEXTROAMPHETAMINE AND COCAINE COMBINATIONS IN COCAINE USERS Alcoholism: Clinical and Experimental Research. 32: 371A-371A. DOI: 10.1111/J.1530-0277.2008.00689_19.X  0.346
2008 Ginsburg BC, Gerak LR, McMahon LR, Roache JD. Neurosteroids in alcohol and substance use Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies For Research and Treatment. 509-538. DOI: 10.1007/978-1-4020-6854-6_25  0.311
2007 Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. The Journal of Pharmacology and Experimental Therapeutics. 322: 749-59. PMID 17502431 DOI: 10.1124/Jpet.107.119693  0.41
2007 Johnson BA, Wells LT, Roache JD, Wallace CL, Ait-Daoud N, Dawes MA, Liu L, Wang XQ, Javors MA. Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 455-61. PMID 17184890 DOI: 10.1016/J.Pnpbp.2006.11.011  0.396
2007 Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 123-30. PMID 16978753 DOI: 10.1016/J.Pnpbp.2006.08.002  0.339
2007 Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ. Effects of acute topiramate dosing on methamphetamine-induced subjective mood. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 85-98. PMID 16448579 DOI: 10.1017/S1461145705006401  0.441
2006 Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence. Drug and Alcohol Dependence. 84: 256-63. PMID 16631323 DOI: 10.1016/J.Drugalcdep.2006.02.011  0.376
2006 Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF, Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcoholism, Clinical and Experimental Research. 30: 185-93. PMID 16441267 DOI: 10.1111/J.1530-0277.2006.00029.X  0.308
2006 Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1537-44. PMID 16319910 DOI: 10.1038/Sj.Npp.1300979  0.376
2005 Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, Murff WL. Effects of repeated-dose isradipine on the abuse liability of cocaine. Experimental and Clinical Psychopharmacology. 13: 319-26. PMID 16366762 DOI: 10.1037/1064-1297.13.4.319  0.353
2005 Johnson BA, Ait-Daoud N, Roache JD. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. Journal of Studies On Alcohol. Supplement. 157-67; discussion 1. PMID 16223067 DOI: 10.15288/Jsas.2005.S15.157  0.335
2005 Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182: 426-35. PMID 16163531 DOI: 10.1007/S00213-005-0102-8  0.389
2005 Johnson BA, Wells LT, Roache JD, Wallace C, Ait-Daoud N, Wang Y. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. American Journal of Hypertension. 18: 813-22. PMID 15925741 DOI: 10.1016/J.Amjhyper.2005.01.020  0.336
2005 Johnson BA, Roache JD, Ait-Daoud N, Wallace CL, Wells LT, Wang Y, Dawes MA. Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 549-56. PMID 15916717 DOI: 10.1017/S1461145705005511  0.327
2005 Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells L, Dawes M, Wang Y. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 203-13. PMID 15850499 DOI: 10.1017/S1461145704005036  0.412
2005 Wurst FM, Alling C, Aradottir S, Pragst F, Allen JP, Weinmann W, Marmillot P, Ghosh P, Lakshman R, Skipper GE, Neumann T, Spies C, Javors M, Johnson BA, Ait-Daoud N, ... ... Roache JD, et al. Emerging biomarkers: new directions and clinical applications. Alcoholism, Clinical and Experimental Research. 29: 465-73. PMID 15770123 DOI: 10.1097/01.Alc.0000156082.08248.Ab  0.32
2005 Johnson BA, Dawes MA, Roache JD, Wells LT, Ait-Daoud N, Mauldin JB, Wang Y, Lancaster JL, Fox PT. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 928-36. PMID 15758948 DOI: 10.1038/Sj.Jcbfm.9600093  0.348
2005 Johnson BA, Javors MA, Lam YW, Wells LT, Tiouririne M, Roache JD, Ait-Daoud N, Lawson K. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 15-20. PMID 15610940 DOI: 10.1016/J.Pnpbp.2004.08.014  0.398
2005 Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Psychopharmacology. 178: 296-302. PMID 15452681 DOI: 10.1007/S00213-004-1998-0  0.326
2004 Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Mauldin JB. Effects of isradipine on cocaine-induced subjective mood. Journal of Clinical Psychopharmacology. 24: 180-91. PMID 15206666 DOI: 10.1097/01.Jcp.0000115662.45074.C3  0.363
2004 McBride WJ, Lovinger DM, Machu T, Thielen RJ, Rodd ZA, Murphy JM, Roache JD, Johnson BA. Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism. Alcoholism, Clinical and Experimental Research. 28: 257-67. PMID 15112933 DOI: 10.1097/01.Alc.0000113419.99915.Da  0.3
2003 Johnson BA, O'Malley SS, Ciraulo DA, Roache JD, Chambers RA, Sarid-Segal O, Couper D. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Journal of Clinical Psychopharmacology. 23: 281-93. PMID 12826990 DOI: 10.1097/01.Jcp.0000084029.22282.Bb  0.402
2003 Sloan TB, Roache JD, Johnson BA. The role of anxiety in predicting drinking behaviour. Alcohol and Alcoholism (Oxford, Oxfordshire). 38: 360-3. PMID 12814905 DOI: 10.1093/Alcalc/Agg090  0.308
2003 Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 361: 1677-85. PMID 12767733 DOI: 10.1016/S0140-6736(03)13370-3  0.351
2002 Gomez TH, Roache JD, Meisch RA. Relative reinforcing effects of different benzodiazepine doses for rhesus monkeys. Drug and Alcohol Dependence. 68: 275-83. PMID 12393222 DOI: 10.1016/S0376-8716(02)00222-3  0.355
2002 Gomez TH, Roache JD, Meisch RA. Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys. Psychopharmacology. 161: 86-94. PMID 11967635 DOI: 10.1007/S00213-002-1019-0  0.332
2002 Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M. Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology. 160: 408-13. PMID 11919668 DOI: 10.1007/S00213-002-1002-9  0.334
2001 Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker. Alcoholism, Clinical and Experimental Research. 25: 847-9. PMID 11410720 DOI: 10.1111/J.1530-0277.2001.Tb02289.X  0.34
2000 Johnson BA, Roache JD, Javors MA, Diclemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial Journal of the American Medical Association. 284: 963-971. PMID 10944641 DOI: 10.1001/Jama.284.8.963  0.327
2000 Johnson BA, Cloninger CR, Roache JD, Bordnick PS, Ruiz P. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population American Journal On Addictions. 9: 17-27. PMID 10914290 DOI: 10.1080/10550490050172191  0.319
2000 Harris JT, Roache JD, Thornton JE. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention Alcohol and Alcoholism. 35: 319-323. PMID 10905994 DOI: 10.1093/Alcalc/35.4.319  0.311
2000 Roache JD, Grabowski J, Schmitz JM, Creson DL, Rhoades HM. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment Journal of Clinical Psychopharmacology. 20: 61-68. PMID 10653210 DOI: 10.1097/00004714-200002000-00011  0.432
1999 Oswald LM, Roache JD, Rhoades HM. Predictors of individual differences in alprazolam self-medication. Experimental and Clinical Psychopharmacology. 7: 379-90. PMID 10609973 DOI: 10.1037//1064-1297.7.4.379  0.663
1999 Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: A preliminary study Psychopharmacology. 144: 295-300. PMID 10435398 DOI: 10.1007/S002130051007  0.353
1997 Spiga R, Macenski MJ, Meisch RA, Roache JD. Human ethanol self-administration I: The interaction between response requirement and ethanol dose Behavioural Pharmacology. 8: 91-100. PMID 9833005 DOI: 10.1097/00008877-199702000-00010  0.325
1997 Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence: Methylphenidate Journal of Clinical Psychopharmacology. 17: 485-488. PMID 9408812 DOI: 10.1097/00004714-199712000-00008  0.412
1997 Streufert S, Satish U, Pogash R, Gingrich D, Landis R, Roache J, Severs W. Excess coffee consumption in simulated complex work settings: detriment or facilitation of performance? The Journal of Applied Psychology. 82: 774-82. PMID 9337609 DOI: 10.1037/0021-9010.82.5.774  0.351
1997 Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers. Experimental and Clinical Psychopharmacology. 5: 203-15. PMID 9260068 DOI: 10.1037/1064-1297.5.3.203  0.377
1997 Roache JD, Stanley MA, Creson DR, Shah NN, Meisch RA. Alprazolam-reinforced medication use in outpatients with anxiety. Drug and Alcohol Dependence. 45: 143-55. PMID 9179516 DOI: 10.1016/S0376-8716(97)01354-9  0.401
1996 Streufert S, Satish U, Pogash R, Gingrich D, Landis JR, Lonardi L, Miller J, Severs W, Roache JD. Effects of alprazolam on complex human functioning Journal of Applied Social Psychology. 26: 1912-1930. DOI: 10.1111/J.1559-1816.1996.Tb00105.X  0.325
1996 Roache JD, Stanley MA, Creson DL, Meisch RA, Shah NN. Diazepam reinforcement in anxious patients Experimental and Clinical Psychopharmacology. 4: 308-314. DOI: 10.1037//1064-1297.4.3.308  0.387
1995 Streufert S, Pogash R, Braig D, Gingrich D, Kantner A, Landis R, Lonardi L, Roache J, Severs W. Alcohol hangover and managerial effectiveness. Alcoholism, Clinical and Experimental Research. 19: 1141-6. PMID 8561282 DOI: 10.1111/J.1530-0277.1995.Tb01592.X  0.339
1995 Roache JD, Meisch RA, Henningfield JE, Jaffe JH, Klein S, Sampson A. Reinforcing effects of triazolam in sedative abusers: Correlation of drug liking and self-administration measures Pharmacology, Biochemistry and Behavior. 50: 171-179. PMID 7740055 DOI: 10.1016/0091-3057(94)00281-M  0.404
1995 Streufert S, Pogash R, Miller J, Gingrich D, Landis R, Lonardi L, Severs W, Roache JD. Effects of caffeine deprivation on complex human functioning. Psychopharmacology. 118: 377-84. PMID 7568623 DOI: 10.1007/Bf02245937  0.338
1994 Streufert S, Pogash R, Roache J, Severs W, Gingrich D, Landis R, Lonardi L, Kantner A. Alcohol and managerial performance. Journal of Studies On Alcohol. 55: 230-8. PMID 8189744 DOI: 10.15288/Jsa.1994.55.230  0.338
1993 Roache JD, Cherek DR, Bennett RH, Schenkler JC, Cowan KA. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance Journal of Clinical Psychopharmacology. 13: 3-15. PMID 8486815 DOI: 10.1097/00004714-199302000-00002  0.399
1993 Roache JD, Spiga R, Burt DB. Triazolam and ethanol effects on human matching-to-sample performance vary as a function of pattern size and discriminability Drug and Alcohol Dependence. 32: 219-229. PMID 8348874 DOI: 10.1016/0376-8716(93)90086-6  0.315
1993 Cherek DR, Roache JD, Egli M, Davis C, Spiga R, Cowan K. Acute effects of marijuana smoking on aggressive, escape and point-maintained responding of male drug users Psychopharmacology. 111: 163-168. PMID 7870947 DOI: 10.1007/Bf02245518  0.306
1993 Streufert S, Pogash RM, Gingrich D, Kantner A, Lonardi L, Severs W, Landis R, Roache J. Alcohol and Complex Functioning1 Journal of Applied Social Psychology. 23: 847-866. DOI: 10.1111/J.1559-1816.1993.Tb01009.X  0.356
1992 Streufert S, Pogash RM, Roache J, Gingrich D, Landis R, Severs W, Lonardi L, Kantner A. Effects of alcohol intoxication on risk taking, strategy, and error rate in visuomotor performance. The Journal of Applied Psychology. 77: 515-24. PMID 1512185 DOI: 10.1037/0021-9010.77.4.515  0.354
1991 Cherek DR, Spiga R, Roache JD, Cowan KA. Effects of triazolam on human aggressive, escape and point-maintained responding Pharmacology, Biochemistry and Behavior. 40: 835-839. PMID 1816570 DOI: 10.1016/0091-3057(91)90094-I  0.333
1991 ROACHE JD. Performance and physiological measures in abuse liability evaluation British Journal of Addiction. 86: 1595-1600. PMID 1786492 DOI: 10.1111/J.1360-0443.1991.Tb01753.X  0.336
1990 Spiga R, Cherek DR, Roache JD, Cowan KA. The effects of codeine on human aggressive responding International Clinical Psychopharmacology. 5: 195-204. PMID 2230064 DOI: 10.1097/00004850-199007000-00005  0.368
1990 Kirk T, Roache JD, Griffiths RR. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects Journal of Clinical Psychopharmacology. 10: 160-167. PMID 2198294 DOI: 10.1097/00004714-199006000-00002  0.355
1990 Roache JD, Cherek DR, Spiga R, Bennett RH, Cowan KA, Yingling J. Benzodiazepine-induced impairment of matching-to-sample performance in humans Pharmacology, Biochemistry and Behavior. 36: 945-952. PMID 1977179 DOI: 10.1016/0091-3057(90)90104-P  0.313
1990 Roache JD. Addiction potential of benzodiazepines and non-benzodiazepine anxiolytics Advances in Alcohol and Substance Abuse. 9: 103-128. PMID 1974120 DOI: 10.1300/J251V09N01_07  0.343
1990 Roache J, Griffiths R. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration Journal of Clinical Psychopharmacology. 10: 137-138. DOI: 10.1097/00004714-199004000-00015  0.343
1989 Roache JD, Griffiths RR. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration Psychopharmacology. 99: 309-315. PMID 2594898 DOI: 10.1007/Bf00445549  0.391
1987 Roache JD, Griffiths RR. Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans Pharmacology, Biochemistry and Behavior. 26: 801-812. PMID 3602037 DOI: 10.1016/0091-3057(87)90614-9  0.401
1986 Roache JD, Griffiths RR. Repeated administration of diazepam and triazolam to subjects with histories of drug abuse Drug and Alcohol Dependence. 17: 15-29. PMID 3720528 DOI: 10.1016/0376-8716(86)90032-3  0.397
1986 Roache JD, Zabik JE. Effects of benzodiazepines on taste aversions in a two-bottle choice paradigm Pharmacology, Biochemistry and Behavior. 25: 431-437. PMID 3020595 DOI: 10.1016/0091-3057(86)90020-1  0.301
1986 Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects Pharmacology, Biochemistry and Behavior. 24: 1749-1754. PMID 3016764 DOI: 10.1016/0091-3057(86)90515-0  0.308
1985 Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neuroscience and Biobehavioral Reviews. 9: 133-51. PMID 2858078 DOI: 10.1016/0149-7634(85)90039-9  0.394
1984 Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD, Nowowieski P. Comparison of diazepam and oxazepam: Preference, liking and extent of abuse Journal of Pharmacology and Experimental Therapeutics. 229: 501-508. PMID 6716272  0.312
1984 Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD. Relative abuse liability of diazepam and oxazepam: Behavioral and subjective dose effects Psychopharmacology. 84: 147-154. PMID 6438672 DOI: 10.1007/Bf00427437  0.422
Low-probability matches (unlikely to be authored by this person)
2005 Casada JH, Roache JD. Behavioral inhibition and activation in posttraumatic stress disorder. The Journal of Nervous and Mental Disease. 193: 102-9. PMID 15684912 DOI: 10.1097/01.Nmd.0000152809.20938.37  0.299
1994 Dougherty DM, Cherek DR, Roache JD. The effects of smoked marijuana on progressive-interval schedule performance in humans Journal of the Experimental Analysis of Behavior. 62: 73-87. PMID 8064214 DOI: 10.1901/Jeab.1994.62-73  0.298
2006 Casada JH, Roache JD. Dissociation of physiology and behavior in PTSD International Journal of Psychophysiology. 62: 243-248. PMID 16814888 DOI: 10.1016/J.Ijpsycho.2006.04.005  0.298
2020 Pruiksma KE, Hale WJ, Mintz J, Peterson AL, Young-McCaughan S, Wilkerson A, Nicholson K, Dondanville KA, Fina BA, Borah EV, Roache JD, Litz BT, Bryan CJ, Taylor DJ. Predictors of Cognitive Behavioral Therapy for Insomnia (CBTi) Outcomes in Active-Duty U.S. Army Personnel. Behavior Therapy. 51: 522-534. PMID 32586427 DOI: 10.1016/J.Beth.2020.02.001  0.297
1996 Pearson DA, Santos CW, Roache JD, Loveland KA, Casat CD, Farwell EC, Roebuck TM, Lachar D. Effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD: Preliminary findings from a study in progress Journal of Developmental and Physical Disabilities. 8: 313-333. DOI: 10.1007/Bf02578398  0.297
2019 Litz BT, Berke DS, Kline NK, Grimm K, Rusowicz-Orazem L, Resick PA, Foa EB, Wachen JS, McLean CP, Dondanville KA, Borah AM, Roache JD, Young-McCaughan S, Yarvis JS, Mintz J, et al. Patterns and predictors of change in trauma-focused treatments for war-related posttraumatic stress disorder. Journal of Consulting and Clinical Psychology. PMID 31556650 DOI: 10.1037/Ccp0000426  0.296
1987 Roache JD, Griffiths RR. Lorazepam and meprobamate dose effects in humans: Behavioral effects and abuse liability Journal of Pharmacology and Experimental Therapeutics. 243: 978-988. PMID 3694540  0.292
1985 Roache JD, Griffiths RR. Experimental assessment of the relative abuse liability of triazolam and pentobarbital Nida Research Monograph Series. 106-110.  0.289
1985 Roache JD, Griffiths RR. Comparison of triazolam and pentobarbital: Performance impairment, subjective effects and abuse liability Journal of Pharmacology and Experimental Therapeutics. 234: 120-133. PMID 2861282  0.285
2020 Papini S, Young CC, Gebhardt CS, Perrone A, Morikawa H, Otto MW, Roache JD, Smits JAJ. Isradipine enhancement of virtual reality cue exposure for smoking cessation: Rationale and study protocol for a double-blind randomized controlled trial. Contemporary Clinical Trials. 106013. PMID 32335287 DOI: 10.1016/J.Cct.2020.106013  0.284
2013 Somoza EC, Winship D, Gorodetzky CW, Lewis D, Ciraulo DA, Galloway GP, Segal SD, Sheehan M, Roache JD, Bickel WK, Jasinski D, Watson DW, Miller SR, Somoza P, Winhusen T. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. Jama Psychiatry. 70: 630-7. PMID 23575810 DOI: 10.1001/jamapsychiatry.2013.872  0.282
1995 Roache JD, Meisch RA. Findings From Self-Administration Research on the Addiction Potential of Benzodiazepines Psychiatric Annals. 25: 153-157. DOI: 10.3928/0048-5713-19950301-08  0.28
2020 Pruiksma KE, Taylor DJ, Mintz J, Nicholson KL, Rodgers M, Young-McCaughan S, Hall-Clark BN, Fina BA, Dondanville KA, Cobos B, Wardle-Pinkston S, Litz BT, Roache JD, Peterson AL. A pilot randomized controlled trial of cognitive behavioral treatment for trauma-related nightmares in active duty military personnel. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 16: 29-40. PMID 31957648 DOI: 10.5664/Jcsm.8116  0.278
2008 Roache JD, Wallace CL, Miller J. COMMUNITY TREATMENT OF SUBSTANCE DEPENDENCE IN BEXAR COUNTY: A CASE STUDY OF UNMET NEED Alcoholism: Clinical and Experimental Research. 32: 369A-369A. DOI: 10.1111/J.1530-0277.2008.00689_9.X  0.276
2005 Javors MA, Seneviratne C, Roache JD, Ait-Daoud N, Bergeson SE, Walss-Bass MC, Akhtar FZ, Johnson BA. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 7-13. PMID 15610939 DOI: 10.1016/J.Pnpbp.2004.08.004  0.273
2004 Pearson DA, Lane DM, Santos CW, Casat CD, Jerger SW, Loveland KA, Faria LP, Mansour R, Henderson JA, Payne CD, Roache JD, Lachar D, Cleveland LA. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response. Journal of the American Academy of Child and Adolescent Psychiatry. 43: 686-98. PMID 15167085 DOI: 10.1097/01.Chi.0000120024.14101.96  0.272
2020 Fredman SJ, Macdonald A, Monson CM, Dondanville KA, Blount TH, Hall-Clark BN, Fina BA, Mintz J, Litz BT, Young-McCaughan S, Hancock AK, Rhoades GK, Yarvis JS, Resick PA, Roache JD, et al. Intensive, Multi-Couple Group Therapy for PTSD: A Nonrandomized Pilot Study With Military and Veteran Dyads. Behavior Therapy. 51: 700-714. PMID 32800299 DOI: 10.1016/J.Beth.2019.10.003  0.267
1993 Griffiths RR, Evans SM, Guarino JJ, Roache JD, Furman WR, Liebson I, Schwam EM. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: Antagonism and precipitated withdrawal Journal of Pharmacology and Experimental Therapeutics. 265: 1163-1174. PMID 8510001  0.263
2004 Lam YW, Javors MA, Ait-Daoud N, Roache JD, Johnson BA. Relative bioavailability of an extemporaneous ondansetron 4-mg capsule formulation versus solution. Pharmacotherapy. 24: 477-81. PMID 15098801 DOI: 10.1592/Phco.24.5.477.33353  0.261
2008 Johnson BA, Javors MA, Roache JD, Seneviratne C, Bergeson SE, Ait-Daoud N, Dawes MA, Ma JZ. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 209-16. PMID 17950969 DOI: 10.1016/J.Pnpbp.2007.07.030  0.26
2003 Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 209-16. PMID 12544181 DOI: 10.1097/00004583-200302000-00015  0.259
2011 Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R, Rivera O, Anderson A, Mojsiak J, Elkashef A. A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug and Alcohol Dependence. 119: 37-45. PMID 21696894 DOI: 10.1016/J.Drugalcdep.2011.05.015  0.257
2004 Pearson DA, Santos CW, Casat CD, Lane DM, Jerger SW, Roache JD, Loveland KA, Lachar D, Faria LP, Payne CD, Cleveland LA. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 43: 677-85. PMID 15167084 DOI: 10.1097/01.Chi.0000124461.81324.13  0.254
2019 Baig MR, Tapia RN, Meraj A, Pugh JA, Roache JD, Finley EP. Enhancing Access to Psychiatric Care for Posttraumatic Stress Disorder in Veterans with Mild Traumatic Brain Injury through Integrated Services. The Psychiatric Quarterly. PMID 31446544 DOI: 10.1007/S11126-019-09668-7  0.254
2020 Taylor DJ, Pruiksma KE, Hale W, McLean CP, Zandberg L, Brown L, Mintz J, Young-McCaughan S, Peterson AL, Yarvis JS, Dondanville KA, Litz BT, Roache J, Foa EB. Sleep Problems in Active Duty Military Personnel Seeking Treatment for Posttraumatic Stress Disorder: Presence, Change, and Impact on Outcomes. Sleep. PMID 32246153 DOI: 10.1093/Sleep/Zsaa065  0.254
1991 Roache JD. Reinforcing and stimulus effects of benzodiazepines in humans Pharmacology Biochemistry and Behavior. 39: 232. DOI: 10.1016/0091-3057(91)90462-B  0.254
2020 Miles SR, Kent TA, Stanley M, Thompson KE, Sharp C, Niles BL, Young-McCaughan S, Mintz J, Roache JD, Litz BT, Hale WJ, Stanford MS, Keane TM, Peterson AL. Manage Emotions to Reduce Aggression: A Pilot Study of a Brief Treatment to Help Veterans Reduce Impulsive Aggression. The Journal of Nervous and Mental Disease. PMID 32947454 DOI: 10.1097/Nmd.0000000000001229  0.253
2015 Dougherty DM, Mullen J, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Mathias CW, Roache JD. Effects of tryptophan depletion and a simulated alcohol binge on impulsivity. Experimental and Clinical Psychopharmacology. 23: 109-21. PMID 25730415 DOI: 10.1037/A0038943  0.251
1994 Stewart RB, Lemaire GA, Roache JD, Meisch RA. Establishing benzodiazepines as oral reinforcers: midazolam and diazepam self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 271: 200-11. PMID 7965716  0.247
2020 Pruiksma KE, Hale W, Mintz J, Peterson A, Young-McCaughan S, Wilkerson A, Nicholson K, Dondanville K, Fina B, Borah E, Roache J, Litz BT, Bryan C, Taylor DJ. 0483 Predictors of Cognitive Behavioral Therapy for Insomnia (CBT) Outcomes in Active Duty U.S. Army Personnel Sleep. 43. DOI: 10.1093/Sleep/Zsaa056.480  0.239
1985 Griffiths RR, Bigelow GE, Liebson IA, Roache JD. Dose effect and preference comparison of diazepam and oxazepam Nida Research Monograph Series. 97-98.  0.238
2022 Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35046508 DOI: 10.1038/s41386-022-01266-9  0.238
2019 Abdallah CG, Roache JD, Averill LA, Young-McCaughan S, Martini B, Gueorguieva R, Amoroso T, Southwick SM, Guthmiller K, López-Roca AL, Lautenschlager K, Mintz J, Litz BT, Williamson DE, Keane TM, et al. Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial. Contemporary Clinical Trials. PMID 30999057 DOI: 10.1016/J.Cct.2019.04.009  0.237
1987 Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacology Series. 3: 83-7. PMID 3823094 DOI: 10.1007/978-3-642-71288-3_10  0.235
2013 Johnson BA, Roache JD, Ait-Daoud N, Gunderson EW, Haughey HM, Wang XQ, Liu L. Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking. Addiction Biology. 18: 405-16. PMID 23039088 DOI: 10.1111/J.1369-1600.2012.00499.X  0.232
1989 Spiga R, Cherek DR, Meisch RA, Roache JD. The effects of triazolam (HALCION) on human multi-operant responding Pharmacology Biochemistry and Behavior. 32: 1085-1086. DOI: 10.1016/0091-3057(89)90117-2  0.229
2019 Dondanville KA, Wachen JS, Hale WJ, Mintz J, Roache JD, Carson C, Litz BT, Yarvis JS, Young-McCaughan S, Peterson AL, Resick PA. Examination of Treatment Effects on Hazardous Drinking Among Service Members With Posttraumatic Stress Disorder. Journal of Traumatic Stress. PMID 30920684 DOI: 10.1002/Jts.22393  0.223
2020 Straud CL, Dondanville KA, Hale WJ, Wachen JS, Mintz J, Litz BT, Roache JD, Yarvis JS, Young-McCaughan S, Peterson AL, Resick PA. The Impact of Hazardous Drinking Among Active Duty Military With Posttraumatic Stress Disorder: Does Cognitive Processing Therapy Format Matter? Journal of Traumatic Stress. PMID 33078467 DOI: 10.1002/jts.22609  0.221
1983 Zabik JE, Roache JD, Johnson W. Dependence liability of caffeine, cocaine, nicotine and phencyclidine Research Communications in Substances of Abuse. 4: 93-96.  0.216
2018 Back SE, Flanagan JC, Jones JL, Augur I, Peterson AL, Young-McCaughan S, Shirley DW, Henschel A, Joseph JE, Litz BT, Hancock AK, Roache JD, Mintz J, Wachen JS, Keane TM, et al. Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans. Contemporary Clinical Trials. PMID 30145268 DOI: 10.1016/J.Cct.2018.08.009  0.207
2018 Mathias CW, Hill-Kapturczak N, Karns-Wright TE, Mullen J, Roache JD, Fell JC, Dougherty DM. Translating transdermal alcohol monitoring procedures for contingency management among adults recently arrested for DWI. Addictive Behaviors. PMID 29397211 DOI: 10.1016/J.Addbeh.2018.01.033  0.206
2015 Dougherty DM, Lake SL, Hill-Kapturczak N, Liang Y, Karns TE, Mullen J, Roache JD. Using contingency management procedures to reduce at-risk drinking in heavy drinkers. Alcoholism, Clinical and Experimental Research. 39: 743-51. PMID 25833033 DOI: 10.1111/Acer.12687  0.205
2020 Keizer BM, Roache JD, Jones JR, Kalpinski RJ, Porcerelli JH, Krystal JH. Continuous Ketamine Infusion for Pain as an Opportunity for Psychotherapy for PTSD: A Case Series of Ketamine-Enhanced Psychotherapy for PTSD and Pain (KEP-P2). Psychotherapy and Psychosomatics. 1-4. PMID 32248200 DOI: 10.1159/000507095  0.203
2016 Mullen J, Mathias CW, Karns TE, Liang Y, Hill-Kapturczak N, Roache JD, Lamb RJ, Dougherty DM. Behavioral Impulsivity Does Not Predict Naturalistic Alcohol Consumption or Treatment Outcomes. Addictive Disorders & Their Treatment. 15: 120-128. PMID 27746702 DOI: 10.1097/Adt.0000000000000085  0.202
2018 Lopez-Cruzan M, Hill-Kapturczak NS, Sanchez JJ, Roache JD, Wright T, Dougherty D, Javors M. 2375 Pharmacokinetics of phosphatidylethanol 16:0/20:4 homolog in human blood after consumption of 0.4 and 0.8 g/kg alcohol in a laboratory clinical study Journal of Clinical and Translational Science. 2: 23-23. DOI: 10.1017/cts.2018.107  0.202
2023 McGeary CA, Morland LA, Resick PA, Straud CL, Moring JC, Sohn MJ, Mackintosh MA, Young-McCaughan S, Acierno R, Rauch SAM, Mintz J, McGeary DD, Wells SY, Grubbs K, Nabity PS, ... ... Roache JD, et al. Impact and efficiency of treatment across two PTSD clinical trials comparing in-person and telehealth service delivery formats. Psychological Services. PMID 37347913 DOI: 10.1037/ser0000774  0.199
2020 Baig MR, Ouyang S, Mata-Galán E, Dawes MA, Roache JD. A Comparison of Cognitive Processing Therapy and Seeking Safety for the Treatment of Posttraumatic Stress Disorder in Veterans. The Psychiatric Quarterly. PMID 32964375 DOI: 10.1007/s11126-020-09850-2  0.197
2012 Roache JD. Commentary on comparison of alcoholism subtypes as moderators of the response to sertraline treatment. Alcoholism, Clinical and Experimental Research. 36: 561-3. PMID 22432698 DOI: 10.1111/j.1530-0277.2012.01781.x  0.195
2018 Karns-Wright TE, Dougherty DM, Hill-Kapturczak N, Mathias CW, Roache JD. The correspondence between transdermal alcohol monitoring and daily self-reported alcohol consumption. Addictive Behaviors. 85: 147-152. PMID 29910035 DOI: 10.1016/J.Addbeh.2018.06.006  0.195
2023 Dougherty DM, Moon TJ, Liang Y, Roache JD, Lamb RJ, Mathias CW, Wasserman AM, Wood EE, Hill-Kapturczak N. Effectiveness of contingency management using transdermal alcohol monitoring to reduce heavy drinking among driving while intoxicated (DWI) arrestees: A randomized controlled trial. Alcohol, Clinical & Experimental Research. 47: 1989-2001. PMID 37864527 DOI: 10.1111/acer.15180  0.194
2016 Javors MA, Hill-Kapturczak N, Roache JD, Karns-Wright TE, Dougherty DM. Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study. Alcoholism, Clinical and Experimental Research. PMID 27130527 DOI: 10.1111/Acer.13062  0.193
2015 Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N. Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking. Drug and Alcohol Dependence. 148: 77-84. PMID 25582388 DOI: 10.1016/J.Drugalcdep.2014.12.021  0.193
2015 Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Cates SE, Roache JD. The Potential Clinical Utility of Transdermal Alcohol Monitoring Data to Estimate the Number of Alcoholic Drinks Consumed. Addictive Disorders & Their Treatment. 14: 124-130. PMID 26500459 DOI: 10.1097/Adt.0000000000000060  0.192
2018 Lopez-Cruzan M, Roache JD, Hill-Kapturczak N, Karns-Wright TE, Dougherty DM, Sanchez JJ, Koek W, Javors MA. Pharmacokinetics of Phosphatidylethanol 16:0/20:4 in Human Blood After Alcohol Intake. Alcoholism, Clinical and Experimental Research. PMID 30091144 DOI: 10.1111/Acer.13865  0.191
2014 Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Cates SE, Lake SL, Mullen J, Roache JD. Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use. Drug and Alcohol Dependence. 142: 301-6. PMID 25064019 DOI: 10.1016/J.Drugalcdep.2014.06.039  0.19
2018 Hill-Kapturczak N, Dougherty DM, Roache JD, Karns-Wright TE, Javors MA. Differences in the Synthesis and Elimination of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 after Acute Doses of Alcohol. Alcoholism, Clinical and Experimental Research. PMID 29505133 DOI: 10.1111/Acer.13620  0.189
2020 Moon TJ, Mathias CW, Mullen J, Karns-Wright TE, Hill-Kapturczak N, Roache JD, Dougherty DM. Social Support and the Rehabilitation of Alcohol-Impaired Drivers: Drinking Motives as Moderators. Health Communication. 1-11. PMID 32091242 DOI: 10.1080/10410236.2020.1731914  0.189
2019 Baig MR, Wilson JL, Lemmer JA, Beck RD, Peterson AL, Roache JD. Enhancing Completion of Cognitive Processing Therapy for Posttraumatic Stress Disorder with Quetiapine in Veterans with Mild Traumatic Brain Injury: a Case Series. The Psychiatric Quarterly. PMID 31054021 DOI: 10.1007/S11126-019-09638-Z  0.188
2019 Mathias CW, Moon TJ, Karns-Wright TE, Hill-Kapturczak N, Roache JD, Mullen J, Dougherty DM. Estimating resource utilization demands in implementing statewide screening, brief intervention, and referral to treatment for alcohol-impaired drivers. Traffic Injury Prevention. 1-8. PMID 30715916 DOI: 10.1080/15389588.2018.1528500  0.187
2021 Roache JD, Pavlicova M, Campbell A, Choo TH, Peavy M, Kermack AS, Nunes EV, Rotrosen J. Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcoholism, Clinical and Experimental Research. PMID 34698397 DOI: 10.1111/acer.14729  0.185
2018 Peterson AL, Resick PA, Mintz J, McCaughan-Young S, McGeary DD, McGeary CA, Velligan DI, Macdonald A, Mata-Galan E, Holliday SL, Dillon KH, Roache JD, Christians IW, Moring JC, Bira LM, et al. Design of a clinical effectiveness trial of in-home cognitive processing therapy for combat-related PTSD. Contemporary Clinical Trials. PMID 30144629 DOI: 10.1016/J.Cct.2018.08.005  0.185
1989 Guarino JJ, Roache JD, Kirk WT, Griffiths RR. Comparison of the behavioral effects and abuse liability of ethanol and pentobabital in recreational sedative abusers Nida Research Monograph Series. 453-454. PMID 2701315  0.184
2014 Hill-Kapturczak N, Lake SL, Roache JD, Cates SE, Liang Y, Dougherty DM. Do variable rates of alcohol drinking alter the ability to use transdermal alcohol monitors to estimate peak breath alcohol and total number of drinks? Alcoholism, Clinical and Experimental Research. 38: 2517-22. PMID 25335857 DOI: 10.1111/Acer.12528  0.182
2016 Mullen J, Mathias CW, Karns TE, Liang Y, Hill-Kapturczak N, Roache JD, Lamb RJ, Dougherty DM. Behavioral Impulsivity Does Not Predict Naturalistic Alcohol Consumption or Treatment Outcomes Addictive Disorders and Their Treatment. DOI: 10.1097/ADT.0000000000000085  0.18
2022 Peterson AL, Straud CL, Young-McCaughan S, McCallin JP, Hoch M, Roux NP, Koch L, Lara-Ruiz J, Roache JD, Hein JM, Blount TH. Combining a stellate ganglion block with prolonged exposure therapy for posttraumatic stress disorder: A nonrandomized clinical trial. Journal of Traumatic Stress. PMID 36050896 DOI: 10.1002/jts.22873  0.18
2012 Ait-Daoud N, Seneviratne C, Smith JB, Roache JD, Dawes MA, Liu L, Wang XQ, Johnson BA. Preliminary Evidence for cue-induced Alcohol Craving Modulated by Serotonin Transporter Gene Polymorphism rs1042173. Frontiers in Psychiatry. 3: 6. PMID 22355291 DOI: 10.3389/Fpsyt.2012.00006  0.179
2022 Wood EE, Liang Y, Moon TJ, Wasserman AM, Lamb RJ, Roache JD, Hill-Kapturczak N, Dougherty DM. Reduced alcohol use increases drink-refusal self-efficacy: Evidence from a contingency management study for DWI arrestees. Drug and Alcohol Dependence. 242: 109706. PMID 36493503 DOI: 10.1016/j.drugalcdep.2022.109706  0.177
2023 Moring JC, Peterson AL, Straud CL, Ortman J, Mintz J, Young-McCaughan S, McGeary CA, McGeary DD, Litz BT, Macdonald A, Roache JD, Resick PA. The interactions between patient preferences, expectancies, and stigma contribute to posttraumatic stress disorder treatment outcomes. Journal of Traumatic Stress. PMID 37883128 DOI: 10.1002/jts.22982  0.176
2022 Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, et al. Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35545665 DOI: 10.1038/s41386-022-01339-9  0.174
2015 Hill-Kapturczak N, Roache JD, Liang Y, Karns TE, Cates SE, Dougherty DM. Accounting for sex-related differences in the estimation of breath alcohol concentrations using transdermal alcohol monitoring. Psychopharmacology. 232: 115-23. PMID 24923985 DOI: 10.1007/S00213-014-3644-9  0.171
2016 Karns-Wright TE, Roache JD, Hill-Kapturczak N, Liang Y, Mullen J, Dougherty DM. Time Delays in Transdermal Alcohol Concentrations Relative to Breath Alcohol Concentrations. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 27522029 DOI: 10.1093/Alcalc/Agw058  0.171
1989 Roache JD, Griffiths RR. Abuse liability of anxiolytics and sedative/hypnotics: methods assessing the likelihood of abuse Nida Research Monograph. 92: 123-146. PMID 2574414  0.165
2014 Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Cates SE, Roache JD. The Potential Clinical Utility of Transdermal Alcohol Monitoring Data to Estimate the Number of Alcoholic Drinks Consumed Addictive Disorders and Their Treatment. DOI: 10.1097/ADT.0000000000000060  0.163
2015 Roache JD, Karns TE, Hill-Kapturczak N, Mullen J, Liang Y, Lamb RJ, Dougherty DM. Using Transdermal Alcohol Monitoring to Detect Low-Level Drinking. Alcoholism, Clinical and Experimental Research. 39: 1120-7. PMID 25988708 DOI: 10.1111/Acer.12750  0.16
2015 Anderson AL, Li SH, Markova D, Holmes TH, Chiang N, Kahn R, Campbell J, Dickerson DL, Galloway GP, Haning W, Roache JD, Stock C, Elkashef AM. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 150: 170-4. PMID 25818061 DOI: 10.1016/j.drugalcdep.2015.01.036  0.159
2018 Roache JD, Karns-Wright TE, Goros M, Hill-Kapturczak N, Mathias CW, Dougherty DM. Processing Transdermal Alcohol Concentration (TAC) data to Detect Low-Level Drinking. Alcohol (Fayetteville, N.Y.). PMID 30179708 DOI: 10.1016/J.Alcohol.2018.08.014  0.159
1989 Bennett RH, Cherek DR, Roache JD, Rose JE. Effects of controlled nicotine doses upon punished and non-punished responding in humans. Nida Research Monograph. 95: 438-9. PMID 2641021  0.158
2009 Dawes MA, Roache JD, Javors MA, Bergeson SE, Richard DM, Mathias CW, Ait-Daoud N, Dougherty DM, Johnson BA. Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter. Journal of Studies On Alcohol and Drugs. 70: 899-907. PMID 19895766 DOI: 10.15288/Jsad.2009.70.899  0.158
2018 Peterson AL, Foa EB, Blount TH, McLean CP, Shah DV, Young-McCaughan S, Litz BT, Schobitz RP, Castillo DT, Rentz TO, Yarvis JS, Dondanville KA, Fina BA, Hall-Clark BN, Brown LA, ... ... Roache JD, et al. Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemporary Clinical Trials. PMID 30055335 DOI: 10.1016/J.Cct.2018.07.016  0.157
2022 Peterson AL, Mintz J, Moring JC, Straud CL, Young-McCaughan S, McGeary CA, McGeary DD, Litz BT, Velligan DI, Macdonald A, Mata-Galan E, Holliday SL, Dillon KH, Roache JD, Bira LM, et al. In-office, in-home, and telehealth cognitive processing therapy for posttraumatic stress disorder in veterans: a randomized clinical trial. Bmc Psychiatry. 22: 41. PMID 35038985 DOI: 10.1186/s12888-022-03699-4  0.156
2024 Straud CL, Roache JD, Ginsburg BC, Baig RM, King VL, Barron S, Blount TH, Young-McCaughan S, Peterson AL. Enhancing massed prolonged exposure with cannabidiol to improve posttraumatic stress disorder: Design and methodology of a pilot randomized clinical trial. Contemporary Clinical Trials Communications. 38: 101270. PMID 38404650 DOI: 10.1016/j.conctc.2024.101270  0.156
1984 Roache JD, Griffiths RR. Subjective and amnesic effects of triazolam (TZ) and pentobarbital (PB) Federation Proceedings. 43.  0.155
2016 Resick PA, Wachen JS, Dondanville KA, Pruiksma KE, Yarvis JS, Peterson AL, Mintz J, Borah EV, Brundige A, Hembree EA, Litz BT, Roache JD, Young-McCaughan S. Effect of Group vs Individual Cognitive Processing Therapy in Active-Duty Military Seeking Treatment for Posttraumatic Stress Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27893032 DOI: 10.1001/Jamapsychiatry.2016.2729  0.155
2016 Dondanville KA, Blankenship AE, Molino A, Resick PA, Wachen JS, Mintz J, Yarvis JS, Litz BT, Borah EV, Roache JD, Young-McCaughan S, Hembree EA, Peterson AL. Qualitative examination of cognitive change during PTSD treatment for active duty service members. Behaviour Research and Therapy. 79: 1-6. PMID 26874683 DOI: 10.1016/J.Brat.2016.01.003  0.153
2018 Moon TJ, Mathias CW, Mullen J, Karns-Wright TE, Hill-Kapturczak N, Roache JD, Dougherty DM. The Role of Social Support in Motivating Reductions in Alcohol Use: A Test of Three Models of Social Support in Alcohol-Impaired Drivers. Alcoholism, Clinical and Experimental Research. PMID 30431660 DOI: 10.1111/Acer.13911  0.153
2017 Cigrang JA, Rauch SA, Mintz J, Brundige AR, Mitchell JA, Najera E, Litz BT, Young-McCaughan S, Roache JD, Hembree EA, Goodie JL, Sonnek SM, Peterson AL. Moving effective treatment for posttraumatic stress disorder to primary care: A randomized controlled trial with active duty military. Families, Systems & Health : the Journal of Collaborative Family Healthcare. 35: 450-462. PMID 29283612 DOI: 10.1037/Fsh0000315  0.149
2018 Taylor DJ, Peterson AL, Pruiksma KE, Hale WJ, Young-McCaughan S, Wilkerson A, Nicholson K, Litz BT, Dondanville KA, Roache JD, Borah EV, Brundige A, Mintz J. Impact of Cognitive Behavioral Therapy for Insomnia Disorder on Sleep and Comorbid Symptoms in Military Personnel: A Randomized Clinical Trial. Sleep. PMID 29618098 DOI: 10.1093/Sleep/Zsy069  0.148
2008 Elkashef A, Anderson A, Li S, Kahn R, Ciraulo D, Reid M, Roache J, Urschel H, Somoza E, Salloum I. Modafinil for cocaine addiction: Multi-site clinical trial European Psychiatry. 23: S307-S308. DOI: 10.1016/J.EURPSY.2008.01.1056  0.147
2018 Foa EB, McLean CP, Zang Y, Rosenfield D, Yadin E, Yarvis JS, Mintz J, Young-McCaughan S, Borah EV, Dondanville KA, Fina BA, Hall-Clark BN, Lichner T, Litz BT, Roache J, et al. Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial. Jama. 319: 354-364. PMID 29362795 DOI: 10.1001/Jama.2017.21242  0.147
2019 Pruiksma KE, Taylor DJ, Mintz J, Nicholson KL, Rodgers M, Young-McCaughan S, Hall-Clark BN, Fina BA, Dondanville KA, Cobos B, Wardle-Pinkston S, Litz BT, Roache JD, Peterson AL. A pilot randomized controlled trial of cognitive behavioral treatment for trauma-related nightmares in active duty military personnel. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. PMID 31770093  0.145
2023 Stanley IH, Marx BP, Fina BA, Young-McCaughan S, Tyler HC, Sloan DM, Blankenship AE, Dondanville KA, Walker JL, Boffa JW, Bryan CJ, Brown LA, Straud CL, Mintz J, Abdallah CG, ... ... Roache JD, et al. Psychometric Properties of the Self-Injurious Thoughts and Behaviors Interview-Short Form Among U.S. Active Duty Military Service Members and Veterans. Assessment. 10731911221143979. PMID 36644835 DOI: 10.1177/10731911221143979  0.136
2020 Baig MR, Beck RD, Wilson JL, Lemmer JA, Meraj A, Meyer EC, Mintz J, Peterson AL, Roache JD. Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study. Military Medical Research. 7: 46. PMID 33032657 DOI: 10.1186/s40779-020-00278-0  0.136
2011 Johnson BA, Ait-Daoud N, Seneviratne C, Roache JD, Javors MA, Wang XQ, Liu L, Penberthy JK, DiClemente CC, Li MD. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. The American Journal of Psychiatry. 168: 265-75. PMID 21247998 DOI: 10.1176/Appi.Ajp.2010.10050755  0.136
2013 Peterson AL, Roache JD, Raj J, Young-McCaughan S. The need for expanded monitoring of adverse events in behavioral health clinical trials. Contemporary Clinical Trials. 34: 152-4. PMID 23117077 DOI: 10.1016/J.Cct.2012.10.009  0.134
2022 Olin CC, McDevitt-Murphy ME, Murphy JG, Zakarian RJ, Roache JD, Young-McCaughan S, Litz BT, Keane TM, Peterson AL. The associations between posttraumatic stress disorder and delay discounting, future orientation, and reward availability: A behavioral economic model. Journal of Traumatic Stress. PMID 35437823 DOI: 10.1002/jts.22820  0.127
2023 Peterson AL, Blount TH, Foa EB, Brown LA, McLean CP, Mintz J, Schobitz RP, DeBeer BR, Mignogna J, Fina BA, Evans WR, Synett S, Hall-Clark BN, Rentz TO, Schrader C, ... ... Roache JD, et al. Massed vs Intensive Outpatient Prolonged Exposure for Combat-Related Posttraumatic Stress Disorder: A Randomized Clinical Trial. Jama Network Open. 6: e2249422. PMID 36602803 DOI: 10.1001/jamanetworkopen.2022.49422  0.127
2019 Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N. Corrigendum to “Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking”. Drug and Alcohol Dependence. 149: 304. PMID 29039886 DOI: 10.1016/j.drugalcdep.2015.01.037  0.124
1989 Spiga R, Cherek DR, Meisch RA, Roache JD. Human multioperant responding: Effects of triazolam Nida Research Monograph Series. 477-478. PMID 2641038  0.122
2019 Brown LA, McLean CP, Zang Y, Zandberg L, Mintz J, Yarvis JS, Litz BT, Peterson AL, Bryan CJ, Fina B, Petersen J, Dondanville KA, Roache JD, Young-McCaughan S, Foa EB, et al. Does prolonged exposure increase suicide risk? Results from an active duty military sample. Behaviour Research and Therapy. 118: 87-93. PMID 31022593 DOI: 10.1016/J.Brat.2019.04.003  0.121
1993 Roache JD, Cherek DR, Meisch RA, Spiga R. Effects of reinforcement history on benzodiazepine disruption of matching- to-sample (MTS) performance Nida Research Monograph Series. 273.  0.121
2023 Benfer N, Grunthal B, Dondanville KA, Young-McCaughan S, Blankenship A, Abdallah CG, Back SE, Flanagan J, Foa EB, Fox PT, Krystal JH, Marx BP, McGeary DD, McLean CP, Pruiksma KE, ... ... Roache JD, et al. DSM-5 criterion-a-based trauma types in service members and veterans seeking treatment for posttraumatic stress disorder. Psychological Trauma : Theory, Research, Practice and Policy. PMID 37410416 DOI: 10.1037/tra0001537  0.117
2009 Ait-Daoud N, Roache JD, Dawes MA, Liu L, Wang XQ, Javors MA, Seneviratne C, Johnson BA. Can serotonin transporter genotype predict craving in alcoholism? Alcoholism, Clinical and Experimental Research. 33: 1329-35. PMID 19426172 DOI: 10.1111/J.1530-0277.2009.00962.X  0.117
2017 McLean CP, Zandberg L, Roache JD, Fitzgerald H, Pruiksma KE, Taylor DJ, Dondanville KA, Litz BT, Mintz J, Young-McCaughan S, Yarvis JS, Peterson AL, Foa EB. Caffeine Use in Military Personnel With PTSD: Prevalence and Impact on Sleep. Behavioral Sleep Medicine. 1-11. PMID 28609150 DOI: 10.1080/15402002.2017.1326920  0.112
2019 Abdallah CG, Averill CL, Ramage AE, Averill LA, Alkin E, Nemati S, Krystal JH, Roache JD, Resick P, Young-McCaughan S, Peterson AL, Fox P. Reduced Salience and Enhanced Central Executive Connectivity Following PTSD Treatment. Chronic Stress (Thousand Oaks, Calif.). 3. PMID 31008419 DOI: 10.1177/2470547019838971  0.112
2018 Zang Y, Gay NG, Kaczkurkin AN, McLean CP, Wachen JS, Yarvis JS, Litz BT, Yadin E, Mintz J, Roache JD, Young-McCaughan S, Peterson AL, Foa EB, Resick PA. Factor Structure and Psychometric Properties of the Peritraumatic and Posttraumatic Emotions Questionnaires Among Active Duty Military Personnel With Posttraumatic Stress Disorder. Journal of Traumatic Stress. 31: 826-836. PMID 30548330 DOI: 10.1002/Jts.22350  0.109
2015 Resick PA, Wachen JS, Mintz J, Young-McCaughan S, Roache JD, Borah AM, Borah EV, Dondanville KA, Hembree EA, Litz BT, Peterson AL. A Randomized Clinical Trial of Group Cognitive Processing Therapy Compared With Group Present-Centered Therapy for PTSD Among Active Duty Military Personnel. Journal of Consulting and Clinical Psychology. PMID 25939018 DOI: 10.1037/Ccp0000016  0.108
1983 Zabik JE, Roache JD. 5-Hydroxytryptophan-induced conditioned taste aversion to ethanol in the rat Pharmacology, Biochemistry and Behavior. 18: 785-790. PMID 6304784 DOI: 10.1016/0091-3057(83)90023-0  0.108
1989 Spiga R, Cherek DR, Roache JD, Cowan K. The acute effects of codeine on human aggressive and non-aggressive behavior Nida Research Monograph Series. 479-480. PMID 2701320  0.105
2019 Abdallah CG, Averill CL, Ramage AE, Averill LA, Goktas S, Nemati S, Krystal JH, Roache JD, Resick PA, Young-McCaughan S, Peterson AL, Fox P. Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder. Chronic Stress (Thousand Oaks, Calif.). 3. PMID 31131337 DOI: 10.1177/2470547019850467  0.104
1989 Cherek DR, Bennett RH, Roache JD, Grabowski J. Human aggressive and non-aggressive responding during acute tobacco abstinence Nida Research Monograph Series. 435-436. PMID 2641020  0.103
2015 Lake SL, Hill-Kapturczak N, Liang Y, Roache JD, Mullen J, Karns TE, Dougherty DM. Assessing the Validity of Participant-Derived Compared to Staff-Derived Values to Compute a Binge Score. Alcohol and Alcoholism (Oxford, Oxfordshire). 50: 413-9. PMID 25770137 DOI: 10.1093/Alcalc/Agv018  0.101
2019 Brown LA, Zang Y, Benhamou K, Taylor DJ, Bryan CJ, Yarvis JS, Dondanville KA, Litz BT, Mintz J, Roache JD, Pruiksma KE, Fina BA, Young-McCaughan S, Peterson AL, Foa EB, et al. Mediation of suicide ideation in prolonged exposure therapy for posttraumatic stress disorder. Behaviour Research and Therapy. 119: 103409. PMID 31176888 DOI: 10.1016/J.Brat.2019.103409  0.096
2021 Peterson AL, Young-McCaughan S, Roache JD, Mintz J, Litz BT, Williamson DE, Resick PA, Foa EB, McGeary DD, Dondanville KA, Taylor DJ, Wachen JS, Fox PT, Bryan CJ, McLean CP, et al. STRONG STAR and the consortium to alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations. Contemporary Clinical Trials. 106583. PMID 34600107 DOI: 10.1016/j.cct.2021.106583  0.091
1989 Roache JD, Cherek DR, Cowan KA, Spiga R, Bennett RH, Grabowski J. Effects of triazolam (TZ) on matching-to-sample (MTS) performance in humans Nida Research Monograph Series. 475-476. PMID 2641037  0.089
2009 Miller J, Roache J. Benefits of topiramate treatment in a dual-diagnosis patient. Psychosomatics. 50: 426-7. PMID 19687186 DOI: 10.1176/appi.psy.50.4.426  0.088
2022 Young-McCaughan S, Peterson AL, Mintz J, Hale WJ, Dondanville KA, Borah EV, Blount TH, Blankenship AE, Fina BA, Hall-Clark BN, Hernandez AM, Jacoby VM, Malach SL, Williams JM, Compton KE, ... ... Roache JD, et al. Testing the role of aerobic exercise in the treatment of posttraumatic stress disorder (PTSD) symptoms in U.S. active duty military personnel: a pilot study. Cognitive Behaviour Therapy. 1-16. PMID 35001842 DOI: 10.1080/16506073.2021.2001689  0.085
1979 Zabik JE, Roache JD. The inhibitory effects of 5-hydroxytryptophan (5HTP) on ethanol consumption in fluid deprived rats Federation Proceedings. 38.  0.085
1993 ROACHE JD, CHEREK DR, BENNETT RH, SCHENKLER JC, COWAN KA. Differential Effects of Triazolam and Ethanol on Awareness, Memory, and Psychomotor Performance Journal of Clinical Psychopharmacology. 13: 3???15. DOI: 10.1097/00004714-199302000-00002  0.085
2018 Brown LA, Clapp JD, Kemp JJ, Yarvis JS, Dondanville KA, Litz BT, Mintz J, Roache JD, Young-McCaughan S, Peterson AL, Foa EB. The pattern of symptom change during prolonged exposure therapy and present-centered therapy for PTSD in active duty military personnel. Psychological Medicine. 1-10. PMID 30220261 DOI: 10.1017/S0033291718002714  0.081
2012 McCammon MG, Fogg TT, Jacobsen L, Roache J, Sampson R, Bower CL. From free to free market: cost recovery in federally funded clinical research. Science Translational Medicine. 4: 141cm7. PMID 22764204 DOI: 10.1126/scitranslmed.3003589  0.07
2023 Wasserman AM, Wood EE, Mathias CW, Moon TJ, Hill-Kapturczak N, Roache JD, Dougherty DM. The age-varying effects of adolescent stress on impulsivity and sensation seeking. Journal of Research On Adolescence : the Official Journal of the Society For Research On Adolescence. PMID 37208844 DOI: 10.1111/jora.12854  0.068
2022 Lehinger E, Reed DE, McGeary DD, Hager BN, Roache JD. Impact of Chronic Pain and Perceived Opioid Benefit on Value Domains. Journal of Clinical Psychology in Medical Settings. PMID 35750972 DOI: 10.1007/s10880-022-09889-2  0.067
1987 Cone EJ, Roache JD, Johnson RE. Effects of passive exposure to marijuana smoke Nida Research Monograph. 76: 150-156. PMID 2830518  0.065
1980 Roache JD, Zabik JE. Factors affecting 5-hydroxytryptophan (5-HTP)-induced long term aversion to ethanol in rats Pharmacologist. 22: 370.  0.063
1986 Griffiths RR, Brady JV, Ator NA, Lamb R, Bigelow GE, Roache JD. Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine. Nida Research Monograph. 67: 93-7. PMID 3092102  0.057
1985 Roache JD, Griffiths RR. Differential tolerance development to diazepam (DZ) and Triazolam (TZ) Federation Proceedings. 44.  0.053
2017 Roache J. ‘The Realer, More Enduring and Sentimental Part of Him’: David Foster Wallace’s Personal Library and Marginalia Orbit: a Journal of American Literature. 5. DOI: 10.16995/ORBIT.142  0.036
2016 Roache J. Literary Annotation, from Poe to Twitter Alluvium: 21st-Century Writing, 21st-Century Approaches. 5. DOI: 10.7766/alluvium.v5.4.02  0.01
Hide low-probability matches.